KRAS mutation analysis: A comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients

Knijn, N, Mekenkamp, L J M, Klomp, M, Vink-Börger, M E, Tol, J, Teerenstra, S, Meijer, J W R, Tebar, M +4 more·2011·British Journal of Cancer

DOI 10.1038/bjc.2011.26

Cited by (290)

Items 101–200 of 290

Tumour heterogeneity: principles and practical consequences
Giorgio Stanta, Stephan Wenzel Jahn, Serena Bonin, Gerald Höefler · 2016 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases
Guillaume Passot, Olivier Soubrane, Felice Giuliante, Giuseppe Zimmitti, Diane Goèré, Suguru Yamashita, Jean‐Nicolas Vauthey · 2016 · Liver Cancer
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients
Bruno Vincenzi, Chiara Cremolini, Andrea Sartore Bianchi, Antonio Dello Russo, Francesco Mannavola, Giuseppe Perrone, Francesco Pantano, Fotios Loupakis, Daniele Rossini, Elena Ongaro et al. · 2015 · Oncotarget
RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres
Annemarie Boleij, Véronique Tack, Aliki Taylor, George Kafatos, Sophie Jenkins-Anderson, Lien Tembuyser, Els Dequeker, J. Han van Krieken · 2016 · BMC Cancer
Correlation between Gene Expression of IGF-1R Pathway Markers and Cetuximab Benefit in Metastatic Colorectal Cancer
Huang, Fei, Xu, Li-an, Khambata-Ford, Shirin · 2012 · Clinical Cancer Research
Clonal Evolution Models of Tumor Heterogeneity
Liran I. Shlush, Dov Hershkovitz · 2015 · American Society of Clinical Oncology Educational Book
KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs and beyond
Umberto Malapelle, Chiara Carlomagno, Caterina De Luca, Claudio Bellevicine, Giancarlo Troncone · 2013 · Journal of Clinical Pathology
KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer
Yasuyuki Kawamoto, Katsuya Tsuchihara, Takayuki Yoshino, Naomi Ogasawara, Motohiro Kojima, Masamichi Takahashi, Atsushi Ochiai, Hideaki Bando, Nozomu Fuse, Makoto Tahara et al. · 2012 · British Journal of Cancer
Current and Future Approaches to Target the Epidermal Growth Factor Receptor and Its Downstream Signaling in Metastatic Colorectal Cancer
Michael S. Lee, Scott Kopetz · 2015 · Clinical Colorectal Cancer
Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019)
Li Ren, Dexiang Zhu, Al B. Benson, Bernard Nordlinger, Claus-Henning Koehne, Conor Patrick Delaney, David James Kerr, Heinz‐Josef Lenz, Jia Fan, Jianping Wang et al. · 2020 · European Journal of Surgical Oncology
The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases
Jiří Polívka, Jindra Windrichová, Martin Pešta, Kateřina Houfková, Hana Řezáčková, Tereza Macanova, Ondřej Vyčítal, Radek Kučera, David Slouka, Ondřej Topolčan · 2020 · Cancers
Structured and shared MRI staging lexicon and report of rectal cancer: A consensus proposal by the French Radiology Group (GRERCAR) and Surgical Group (GRECCAR) for rectal cancer
Stéphanie Nougaret, Pascal Rousset, Kirsten L. Gormly, Olivier Lucidarme, Serge Brunelle, Laurent M. Milot, C. Salut, F. Pilleul, Lionel Arrivé, Constance Hordonneau et al. · 2021 · Diagnostic and Interventional Imaging
The value of KRAS gene status in predicting local tumor progression of colorectal liver metastases following radiofrequency ablation
Binbin Jiang, Kun Yan, Zhong-Yi Zhang, Wei Yang, Wei Wu, Shanshan Yin, Minhua Chen · 2019 · International Journal of Hyperthermia
KRAS-targeted therapies in colorectal cancer: a systematic analysis of mutations, inhibitors, and clinical trials
Maria Navarro-Jiménez, Beatríz González, Núria Mulet-Margalef, Cinta Hierro, Sergio Alonso · 2025 · npj Precision Oncology
High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer
Evert van den Broek, Maurits J. J. Dijkstra, Oscar Krijgsman, Daoud Sie, Josien C. Haan, Joleen J.H. Traets, Mark A. van de Wiel, Irıs D. Nagtegaal, Cornelis J.A. Punt, Beatriz G. Carvalho et al. · 2015 · PLoS ONE
KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma
Panagiotis Paliogiannis, Antonio Cossu, Francesco Tanda, Giuseppe Palmieri, Grazia Palomba · 2014 · Oncology Letters
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?
Ribal Bou Mjahed, Christoforos Astaras, Arnaud D. Roth, Thibaud Koessler · 2022 · Current Treatment Options in Oncology
KRAS mutational analysis in ductal adenocarcinoma of the pancreas and its clinical significance
Umberto Miglio, Alberto Oldani, Rosanna Mezzapelle, Claudia Veggiani, Alessia Paganotti, Marcello Garavoglia, Renzo Luciano Boldorini · 2014 · Pathology - Research and Practice
Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer
Kyu‐pyo Kim, Jeong‐Eun Kim, Yong Sang Hong, Sung‐Min Ahn, Sung‐Min Chun, Seung‐Mo Hong, Se Jin Jang, Chang Sik Yu, Jin Cheon Kim, Tae Won Kim · 2016 · Cancer Research and Treatment
A CRISPR-Cas9 repressor for epigenetic silencing of KRAS
Jingwen Liu, Meiyan Sun, Kwang Bog Cho, Xiang Gao, Bin Guo · 2020 · Pharmacological Research
Mutation analysis of KRAS in primary colorectal cancer and matched metastases by means of highly sensitivity molecular assay
Umberto Miglio, Rosanna Mezzapelle, Alessia Paganotti, Sara Allegrini, Claudia Veggiani, Jlenia Antona, Sergio Gentilli, Guido Monga, Oscar Alabiso, Renzo Luciano Boldorini · 2013 · Pathology - Research and Practice
The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer
Wakkas Fadhil, Salih Ibrahem, Rashmi Seth, Ghada AbuAli, Krishna Ragunath, Philip Kaye, Mohammad Ilyas · 2012 · Histopathology
Mutación del gen KRAS en el cáncer de colon y recto
Ivan S. Roa, Tamara Sánchez, Alejandro Majlis, Kurt Alex Schalper · 2013 · Revista médica de Chile
Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases
the DeCoDe PET group, Jeroen A. C. M. Goos, Annemieke C. Hiemstra, Veerle M.H. Coupé, Begoña Diosdado, Wendy Kooijman, Pien M. Delis‐van Diemen, Cemile Karga, Jeroen A.M. Beliën, C. Willemien Menke‐van der Houven van Oordt et al. · 2014 · British Journal of Cancer
Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
Britta Andrea Kleist, Marcel Kempa, Michael Novy, Christian Oberkanins, Li Xu, Guojun Li, Christiane Loland, Micaela Poetsch · 2014 · PubMed Central
Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)
Pilar García Alfonso, Ramón Salazar, Jesús García‐Foncillas, Eva Musulén, Rocio García‐Carbonero, Artemio Payá, Pedro Pérez‐Segura, Santiago Ramón y Cajal, Samuel Navarro · 2012 · Clinical & Translational Oncology
Predicting liver metastases growth patterns: Current status and future possibilities
Rui Caetano Oliveira, Henrique Alexandrino, Maria Augusta Cipriano, Filipe Caseiro‐Alves, José Guilherme Tralhão · 2020 · Seminars in Cancer Biology
EZH2 and CD79B mutational status over time in B‐cell non‐Hodgkin lymphomas detected by high‐throughput sequencing using minimal samples
Mauro Ajaj Saieg, William Robert Geddie, Scott L. Boerner, Denis J Bailey, Michael Crump, Gilda da Cunha Santos · 2013 · Cancer Cytopathology
Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes
Federica Gaiani, Federica Marchesi, Francesca Negri, Luana Greco, Alberto Malesci, Gian Luigi de’Angelis, Luigi Laghi · 2021 · International Journal of Molecular Sciences
Validation of KRAS Testing for Anti-EGFR Therapeutic Decisions for Patients With Metastatic Colorectal Carcinoma
Suzanne Kamel‐Reid, Tong Zhang, Diane L. Persons, Marina N. Nikiforova, Kevin C. Halling, _ _ · 2011 · Archives of Pathology & Laboratory Medicine
Evidence of intermetastatic heterogeneity for pathological response and genetic mutations within colorectal liver metastases following preoperative chemotherapy
Mylène Sebagh, Marc‐Antoine Allard, Nelly Bosselut, Myriam Dao, Éric Vibert, Maïté Lewin, Antoinette Lemoine, Daniel Cherqui, René A. Adam, António Sá Cunha · 2016 · Oncotarget
What is the role of lymph node metastases in the progression of colorectal cancer?
Irıs D. Nagtegaal, Hans‐Joachim Schmoll · 2017 · Nature Reviews Gastroenterology & Hepatology
Relationship between KRAS mutations and dual time point 18F-FDG PET/CT imaging in colorectal liver metastases
Wujian Mao, Jun F. Zhou, He Zhang, Lin Qiu, Hui Tan, Yan Hu, Hongcheng Shi · 2018 · Abdominal Radiology
KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.
Ahmet Şiyar Ekinci, Umut Demırcı, Berna Çakmak Öksüzoğlu, Ayse Ozturk, Onur Eşbah, Tahsin Özatlı, Burcin Celik, Burçin Budakoğlu, İbrahim Türker, Öznur Bal et al. · 2015 · PubMed
Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies
Yuliya Kitsel, Timothy Cooke, Vlasios S. Sotirchos, Constantinos T. Sofocleous · 2023 · Cancers
RAS mutations vary between lesions in synchronous primary Colorectal Cancer: Testing only one lesion is not sufficient to guide anti-EGFR treatment decisions.
Mariana Petaccia de Macêdo, Fernanda Machado de Melo, Júlia S. Ribeiro, Celso Abdon Lopes de Mello, Maria Dirlei Ferreira de Souza Begnami, Fernando Augusto Soares, Dirce Maria Carraro, Isabela Werneck da Cunha · 2015 · Oncoscience
Analysis of KRAS , NRAS , PIK3CA , and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer
Luca Reggiani Bonetti, Valeria Barresi, Stefania Raffaella Bettelli, Cecilia Caprera, Samantha Manfredini, Antonio Maiorana · 2016 · Human Pathology
Personalized treatment for advanced colorectal cancer: KRAS and beyond
Christos Stelios Karapetis, Gargi Surendra Patel · 2013 · Cancer Management and Research
The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases
Stacey A. Cohen, Ming Yu, Kelsey K. Baker, Mary Weber Redman, Chen Wu, Tai J. Heinzerling, Ralph Markus Wirtz, Elpida Charalambous, George E. Pentheroudakis, Vassiliki Kotoula et al. · 2017 · Clinical Epigenetics
Molecular morphometric analysis shows relative intra-tumoural homogeneity for KRAS mutations in colorectal cancer
Liora Farber, Edna Efrati, Hela Elkin, Yehudit Peerless, Edmond Sabo, Ofer Ben‐Izhak, Dov Hershkovitz · 2011 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Activated cMET and IGF1R-Driven PI3K Signaling Predicts Poor Survival in Colorectal Cancers Independent of KRAS Mutational Status
Jeeyun Lee, Anjali Jain, Phillip Kim, Tani Lee, Anne Kuller, Fred Princen, In-Gu, Suk Hyeong Kim, Joon Oh Park, Young Suk Park et al. · 2014 · PLoS ONE
Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases
Shingo Yamashita, Bruno Calazans Odisio, Steven Y. Huang, Scott Kopetz, Kamran Ahrar, Yun Shin Chun, Claudius H. Conrad, Thomas A. Aloia, Sanjay Kumar Gupta, Samer Harmoush et al. · 2017 · European Journal of Surgical Oncology
Spatio-temporal tumor heterogeneity in metastatic CRC tumors: a mutational-based approach
Sofía del Carmen, José María Sayagués, Óscar Bengoechea, María Fernanda Anduaga, José A. Sánchez Alcázar, Ruth Gervás, Jacinto García, Alberto Órfão, Luis Muñoz‐Bellvís, María Eugenia Sarasquete et al. · 2018 · Oncotarget
Colorectal cancer cell exosome and cytoplasmic membrane for homotypic delivery of therapeutic molecules
Ivana Jarak, Ana Isabel Santos, Ana Helena Pinto, Cátia Domingues, Inês S. da Silva, Raquel Melo, Francisco Veiga, Ana Figueiras · 2023 · International Journal of Pharmaceutics
RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps
Yasmijn J. van Herwaarden, Lieke M. Koggel, Femke Simmer, Elisa M. Vink‐Börger, Polat Dura, Gerrit A. Meijer, Fokko M. Nagengast, Nicoline Hoogerbrugge, Tanya M. Bisseling, Irıs D. Nagtegaal · 2020 · Histopathology
Mitochondrial DNA alteration in primary and metastatic colorectal cancer: Different frequency and association with selected clinicopathological and molecular markers
Britta Andrea Kleist, Thuja Meurer, Micaela Poetsch · 2017 · Tumor Biology
Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations
Alessandra Silvestri, Valerie S. Calvert, Claudio Belluco, Michael Lipsky, Ruggero D. Maria, Jianghong Deng, Alfonso Colombatti, Francesco Marchi, Donato Nitti, Enzo Mammano et al. · 2012 · Clinical & Experimental Metastasis
Personalized oncology: genomic screening in phase 1
Ida Viller Tuxen, Lars Jønson, Eric Santoni‐Rugiu, Jane Preuss Hasselby, Finn Cilius Nielsen, Ulrik Lassen · 2014 · Apmis
Adenoma and carcinoma components in colonic tumors show discordance for KRAS mutation
Dov Hershkovitz, Einav Simon, Tova Bick, Elad Prinz, Shawna Noy, Edmond Sabo, Ofer Ben‐Izhak, Michael W. Vieth · 2014 · Human Pathology
Superior outcomes of nodal metastases compared to visceral sites in oligometastatic colorectal cancer treated with stereotactic ablative radiotherapy
Sean Michael O'Cathail, Thomas Smith, Rob Owens, Anthi Zeniou, Yat Man Tsang, D. Holyoake, Louise Janet Murray, Mark Harrison, M. Hawkins · 2020 · Radiotherapy and Oncology
Diagnostic and prognostic biomarkers in colorectal cancer and the potential role of exosomes in drug delivery
Real Sumayya Abdul Sattar, Renu Verma, Nimisha, Arun Kumar, Ghulam Mehdi Dar, Apurva Apurva, Abhay Kumar Sharma, Indu Kumari, Ejaj Ahmad, Asgar Ali et al. · 2022 · Cellular Signalling
A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9
Jeroen A. C. M. Goos, the DeCoDe PET Group, Veerle M.H. Coupé, Mark A. van de Wiel, Begoña Diosdado, Pien M. Delis‐van Diemen, Annemieke C. Hiemstra, Erienne M.V. de Cuba, Jeroen A.M. Beliën, C. Willemien Menke‐van der Houven van Oordt et al. · 2015 · Oncotarget
Colorectal Liver Metastases: Does the Future of Precision Medicine Lie in Genetic Testing?
Carlotta Barbon, Georgios Antonios Margonis, Nikolaos Andreatos, Neda Rezaee, Kazunari Sasaki, Stefan Buettner, Christos Damaskos, Timothy Michael Pawlik, Jin Peng He, Christopher Lee Wolfgang et al. · 2018 · Journal of Gastrointestinal Surgery
The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
Wenli Xie, Li Xie, Xianrang Song · 2019 · Cancer Medicine
The Current Status of Nodal Staging in Rectal Cancer
Amy C. Lord, Nigel D’Souza, Annabel Shaw, Nigel Day, Gina M. Brown · 2019 · Current Colorectal Cancer Reports
KRAS mutation status is highly homogeneous between areas of the primary tumor and the corresponding metastasis of colorectal adenocarcinomas: one less problem in patient care.
Mariana Petaccia de Macêdo, Fernanda Machado de Melo, Héber S. C. Ribeiro, M.C. Marques, Luciane Tsukamoto Kagohara, Maria Dirlei Begnami, Julio Cirullo Neto, Júlia S. Ribeiro, Fernando Augusto Soares, Dirce Maria Carraro et al. · 2017 · Europe PMC (PubMed Central)
Somatic mutation profiles in primary colorectal cancers and matching ovarian metastases: Identification of driver and passenger mutations
Stijn Crobach, Dina Ruano, Ronald van Eijk, Melanie Schrumpf, PALGA group, Gertjan J. Fleuren, Tom van Wezel, Hans Morreau · 2016 · The Journal of Pathology Clinical Research
KRAS discordance between primary and recurrent tumors after radical resection of colorectal cancers
Kyung Ha Lee, Jin Soo Kim, Choong Sik Lee, Jiyeon Kim · 2015 · Journal of Surgical Oncology
Effect of KRAS and BRAF mutations in metastatic colorectal cancer patients: A systematic review and meta-analysis based on tumor sidedness and KRAS subtypes
Khadijeh Saravani, Morteza Salarzaei, Fateme Parooie · 2021 · Human Antibodies
Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients
Zhe-Zhen Li, Long Bai, Feng Wang, Zi-Chen Zhang, Fang Wang, Zhao-Lei Zeng, Jun‐Bo Zeng, Dong-sheng Zhang, Feng‐Hua Wang, Zhiqiang Wang et al. · 2016 · Medical Oncology
Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors
Giuseppe Aprile, Mariaelena Casagrande, Giovanna De Maglio, Caterina Fontanella, Karim Rihawi, Marta Bonotto, Federica Edith Pisa, Francesco Tuniz, Stefano Pizzolitto, Gianpiero Fasola · 2016 · Future Oncology
Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases
Georgios Antonios Margonis, Yuhree Kim, Kazunari Sasaki, Mario J. Samaha, Stefan Buettner, Neda Amini, Timothy Michael Pawlik · 2016 · Journal of Surgical Oncology
Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis
William Torén, Daniel Ansari, Roland E. Andersson · 2018 · Cancer Cell International
Genetic Heterogeneity in Colorectal Cancer and its Clinical Implications
Rui Barranha, José Luís Costa, Fátima Carneiro, José Carlos Machado · 2015 · Acta Médica Portuguesa
Pretreatment 18F-FDG PET/CT Imaging Predicts the KRAS/NRAS/BRAF Gene Mutational Status in Colorectal Cancer
Peng He, Yuan Zou, Jia Qiu, Tianhong Yang, Lei Peng, Xiangsong Zhang · 2021 · Journal of Oncology
A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study
Letizia Procaccio, Francesca Bergamo, Francesca Daniel, Cosimo Rasola, Giada Munari, Paola Biason, Stefania Crucitta, Giulia Barsotti, Giulia Zanella, Valentina Angerilli et al. · 2021 · Cancers
Relationship between KRAS mutation and diffusion weighted imaging in colorectal liver metastases; Preliminary study
Mehmet Ali Gültekin, Hacı Mehmet Türk, Mehmet Beşiroğlu, Hüseyin Toprak, İsmail Yurtsever, Temel Fatih Yılmaz, Rasul Sharifov, Ömer Uysal · 2020 · European Journal of Radiology
KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer
Peter Jo, Markus Bernhardt, Manuel Manfred Nietert, Alexander Otto König, Azadeh Azizian, Markus Schirmer, Marian Grade, Julia Kitz, Kirsten Reuter‐Jessen, Michael B. Ghadimi et al. · 2020 · PLoS ONE
Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases
Yuka Kaneko, Hidekazu Kuramochi, Go Nakajima, Yuji Inoue, Masakazu Yamamoto · 2013 · International Journal of Clinical Oncology
Circulating tumor cells: what we know, what do we want to know about them and are they ready to be used in clinics?
Zuzana Bielčiková, Anna Jakabová, Michael Pinkas, Milada Zemanová, Katarína Kološtová, Vladimír Bobek · 2017 · PubMed Central
IMPACT OF KRAS MUTATIONS IN CLINICAL FEATURES IN COLORECTAL CANCER
Renato Morato Zanatto, Gianni SANTOS, Júnea Cáris de Oliveira, Eduardo Marcucci Pracucho, Adauto José Ferreira Nunes, Gaspar de Jesus Lopes Filho, Sarhan Sydney Saad · 2020 · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection
Francesco Ardito, Francesco Razionale, Lisa Salvatore, Tonia Cenci, Maria Vellone, Michele Basso, Elena Panettieri, Maria Alessandra Calegari, Giampaolo Tortora, Maurizio Martini et al. · 2021 · Cancers
Biomarkers in colorectal liver metastases: Rising complexity and unknown clinical significance?
Markus K. Diener, Stefan Fichtner‐Feigl · 2021 · Annals of Gastroenterological Surgery
Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
Roberto Ivan Lopez, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García et al. · 2018 · ESMO Open
Detecting KRAS mutations in peripheral blood of colorectal cancer patients by peptide nucleic acid clamp PCR
Shozo Miyano, Kisaburo Hanazawa, Toshiaki Kitabatake, Minoru Fujisawa, Kuniaki Kojima · 2012 · Experimental and Therapeutic Medicine
Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatment
Sing Yu Moorcraft, Thomas Jones, Brian A. Walker, George Ladas, Eleftheria Kalaitzaki, Lina Yuan, Ruwaida Begum, Zakaria Eltahir, Andrew Charles Wotherspoon, Ángeles Montero et al. · 2017 · Oncotarget
Review: KRAS mutations are influential in driving hepatic metastases and predicting outcome in colorectal cancer
Colin William Steele, Thomas Whittle, Jesse Joshua Smith · 2019 · Chinese Clinical Oncology
Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer
Linda J.W. Bosch, Geert Trooskens, Pétur Snæbjörnsson, Veerle M.H. Coupé, Sandra Mongera, Josien C. Haan, Susan D. Richman, Miriam Koopman, Jolien Tol, Tim De Meyer et al. · 2017 · Oncotarget
Prevalence of KRAS mutations in metastatic colorectal cancer: A retrospective observational study from India
VH Veldore, MR Rao, SA Prabhudesai, R Tejaswi, S Kakara, S Pattanayak, Naveen Krishnamoorthy, Tejaswini BN, Diganta Hazarika, Aparna Gangoli et al. · 2014 · Indian Journal of Cancer
Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations
Guillaume Passot, Yun Shin Chun, Scott Kopetz, Michael James Overman, Claudius H. Conrad, Thomas A. Aloia, Jean‐Nicolas Vauthey · 2016 · European Journal of Surgical Oncology
Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Pilar García Alfonso, Jesús García‐Foncillas, Ramón Salazar, Pedro Pérez‐Segura, Rocio García‐Carbonero, Eva Musulén, Míriam Cuatrecasas, Stefania Landolfi, Santiago Ramón y Cajal, S. Navarro · 2014 · Clinical & Translational Oncology
Precision Medicine in Colorectal Cancer: Evolving Genomic Landscape and Emerging Consensus
Kurt W. Fisher, Antonio Lopez-beltran B, Rodolfo Montironi, Liang Cheng C · 2015 · Future Oncology
Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (V. 2023)
Li Ren, Dexiang Zhu, Jin Fa Gu, Baoqing Jia, Jin Li, Xinyu Qin, Xishan Wang, Rui‐Hua Xu, Yingjiang Ye, Suzhan Zhang et al. · 2023 · Clinical Surgical Oncology
WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy
Linda J.W. Bosch, Yanxin Luo, Victoria Valinluck Lao, Pétur Snæbjörnsson, Geert Trooskens, Ilse Vlassenbroeck, Sandra Mongera, Weiliang Tang, Piri L. Welcsh, James Gordon Herman et al. · 2016 · Clinical Cancer Research
Meta-analysis of the mutational status of circulation tumor cells and paired primary tumor tissues from colorectal cancer patients
Yong Liu, Stefano Meucci, Liming Sheng, Ulrich Keilholz · 2017 · Oncotarget
Changes of KRAS Exon 2 Codon 12/13 Mutation Status in Recurrent Colorectal Cancer
Ottó Dócs, Ferenc Fazakas, Nóra Lugosiné Horváth, László Tóth, Csilla András, Zsolt Horváth, Gábor Méhes · 2014 · Pathology & Oncology Research
An overview on clinical, pathological and molecular features of lung metastases from colorectal cancer
Letizia Procaccio, Francesca Bergamo, Chiara Manai, Veronica Di Antonio, Matteo Fassan, Vittorina Zagonel, Sara Lonardi, Fotios Loupakis · 2019 · Expert Review of Respiratory Medicine
The association of KRAS mutation with primary tumor location and survival in patients undergoing resection of colorectal cancers and synchronous liver metastases
Niccolò Allievi, Paolo Goffredo, Alan Fremder Utria, Michele Pisano, Elia Poiasina, Alessandro Lucianetti, Paige Zhou, Imran Hassan · 2019 · Chinese Clinical Oncology
Acquired drug resistance conferred by a KRAS gene mutation following the administration of cetuximab: a case report
Osumi, Hiroki, Matsusaka, Satoshi, Shinozaki, Eiji, Suenaga, Mitsukuni, Mingyon, Mun, Saiura, Akio, Ueno, Masashi, Mizunuma, Nobuyuki, Yamaguchi, Toshiharu · 2013 · BMC Research Notes
Multilevel Heterogeneity of Colorectal Cancer Liver Metastasis
Hao Chen, Chongya Zhai, Xian Xu, Haidong Wang, Weidong Han, Jiaying Shen · 2023 · Cancers
KRAS mutational status of endoscopic biopsies matches resection specimens
Qinghua Yang, Jason Schmidt, Genvieve Soucy, Robert Daniel Odze, Liza Dejesa-Jamanila, Keely Arnold, Christine D. Kuslich, Richard H. Lash · 2012 · Journal of Clinical Pathology
Select Biomarkers for Tumors of the Gastrointestinal Tract: Present and Future
Angela N. Bartley, Stanley R. Hamilton · 2014 · Archives of Pathology & Laboratory Medicine
Prevalencia y características de mutaciones somáticas del gen KRAS en pacientes chilenos con cáncer colorectal
Claudia Hurtado, Gonzalo Encina, Ana María Wielandt, Alejandro José Zárate, Magdalena Castro, Katya Carrillo G., Udo Kronberg, Francisco López-Köstner · 2014 · Revista médica de Chile
Conversion therapy with the intent to perform radical local treatment may not be suitable for patients with 10 or more liver metastases from colorectal cancer
Junzhong Lin, Hui Juan Sun, Weili Zhang, Zhigang Hong, Zhenhai Lu, Zhizhong Pan, Zhenlin Hou, Jianhong Peng · 2022 · Cancer Medicine
Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches
Akbar Ali Khan Pathan, Bhavana Panthi, Zahid Khan, Purushotham Reddy Koppula, Mohammad Saud Alanazi, Narasimha Reddy Parine, Mukesh Chourasia, S Sachchidanand · 2016 · OncoTargets and Therapy
Role of specific DNA mutations in the peripheral blood of colorectal cancer patients for the assessment of tumor stage and residual disease following tumor resection
Gregor Norčič, Franc Jelenc, Petra Cerkovnik, Vida Stegel, Srdjan Novaković · 2016 · Oncology Letters
The gene mutational discrepancies between primary and paired metastatic colorectal carcinoma detected by next-generation sequencing
Shuangmei Zou, Weihua Li, Wenmiao Wang, Wenbin Li, Su-Sheng Shi, Jianming Ying, Ning Lyu · 2018 · Journal of Cancer Research and Clinical Oncology
The Presence of Mutations in the K-RAS Gene Does Not Affect Survival after Resection of Pulmonary Metastases from Colorectal Cancer
Jon Zabaleta, Borja Aguinagalde, José M. Izquierdo, Nerea Bazterargui, Stephany Laguna Sanjuanelo, Maialen Martín-Arruti, Carmen Lobo, José Ignacio Emparanza · 2014 · ISRN Surgery
Molecular Analysis of Liquid Cytological Samples Collected by Bronchoscopy with Radial Endobronchial Ultrasonography and Guide Sheath
Naomi Iwabu, Takehiro Izumo, Yukiko Nakamura, Christine Chavez, Takaaki Tsuchida, Shinji Sasada · 2014 · Annals of Thoracic and Cardiovascular Surgery
Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progression
Theodora Germetaki, Camille Nicholls, Richard Adams, Michael Braun, Jane Rogan, Sharzad Moghadam, Eva Lenfert, Antje Lukas, Daniel L. Edelstein, Frederick Scheetz Jones et al. · 2020 · Future Oncology